NCT04487197View on ClinicalTrials.gov

SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)

CompletedOBSERVATIONAL
Enrollment

282

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

January 15, 2021

Study Completion Date

January 15, 2021

Conditions
Kidney TransplantPancreatic TransplatPancreatic Islets Langerhans
Interventions
PROCEDURE

blood sample for seroepidemiological investigation

blood sample for seroepidemiological investigation

Trial Locations (1)

20132

IRCCS San Raffaele, Milan

All Listed Sponsors
lead

Antonio Secchi

OTHER

NCT04487197 - SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets) | Biotech Hunter | Biotech Hunter